AVB
50
3
UNP
32
2
PPL
75
-2
PX
69
16
QRVO
23
13
GLW
55
3
NOV
49
4
CB
55
11
CA
13
-6
CAT
48
4
PYPL
33
4
BK
72
4
LMT
25
-4
HPQ
39
2
THC
61
6
SWK
39
-3
TSCO
52
2
XEL
57
-3
AMAT
42
2
AAL
27
3
AVB
50
3
UNP
32
2
PPL
75
-2
PX
69
16
QRVO
23
13
GLW
55
3
NOV
49
4
CB
55
11
CA
13
-6
CAT
48
4
PYPL
33
4
BK
72
4
LMT
25
-4
HPQ
39
2
THC
61
6
SWK
39
-3
TSCO
52
2
XEL
57
-3
AMAT
42
2
AAL
27
3
Financhill
Back

SBC Medical Group Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
49

SBC
SBC Medical Group Holdings

Last Price:
$3.73
Seasonality Move:
--
Buy
60

ALNY
Alnylam Pharmaceuticals

Last Price:
$280.77
Seasonality Move:
3.3%
Sell
49
SBC Medical Group Holdings (SBC) is a Sell

Is SBC Medical Group Holdings a Buy, Sell or Hold?

  • The current SBC Medical Group Holdings [SBC] share price is $3.86. The Score for SBC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SBC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SBC Stock Price Chart

What is SBC Medical Group Holdings's stock price today?

  • The SBC Medical Group Holdings share price today is $3.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SBC is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $290.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

SBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 46.95 Sell
Chaikin Money Flow: 17254 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.36 - 4.84) Sell
Bollinger Bands (100): (4.39 - 6.65) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.72 Buy
Relative Strength Index (14 RSI): 71.41 Buy
Chaikin Money Flow: -979016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.44 - 263) Buy
Bollinger Bands (100): (240.32 - 271.8) Buy

SBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.43 Buy
20-day SMA: 3.93 Sell
50-day SMA: 4.6 Sell
200-day SMA: 0 Buy
8-day EMA: 3.59 Buy
20-day EMA: 3.86 Sell
50-day EMA: 4.39 Sell
200-day EMA: 3.27 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 257.74 Buy
20-day SMA: 249.75 Buy
50-day SMA: 257.54 Buy
200-day SMA: 251.5 Buy
8-day EMA: 263.89 Buy
20-day EMA: 256.08 Buy
50-day EMA: 255.39 Buy
200-day EMA: 243.44 Buy

SBC Medical Group Holdings Earnings Growth & SBC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

SBC Medical Group Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):